Ophthalmic Drugs Market is Expected to Reach USD 21.6 Billion Globally in 2018: Transparency Market Research

Ophthalmic Drugs Market is Expected toOphthalmic Drugs Market is Expected to Reach USD 21.6 Billion Globally in 2018: Transparency Market Research PR Newswire NEW YORK, January 24, 2014 According to a new market report published by Transparency Market Research "Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti- allergy/inflammatory/infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018," the global ophthalmic drugs market was valued at USD 16 billion in 2012 and is expected to grow at a CAGR of 5.2% from 2013 to 2018, to reach an estimated value of USD 21.6 billion in 2018. Browse the full Ophthalmic Drugs Market Report with TOC at http://www.transparencymarketresearch.com/ophthalmic-drugs- market.html Globally, the ophthalmic drugs market is witnessing significant growth due to increasing prevalence of eye disorders such as diabetic retinopathy and macular degeneration. As a result, this market is expected to grow at a CAGR of about 5.2% during 2013 - 2018. Some of the key driving factors for the ophthalmic drugs market are rising prevalence of global aging population, increasing government initiatives towards healthcare infrastructure in developing countries (such as India and China), technological changes in drug delivery technique, and increasing prevalence of lifestyle associated diseases.